Sichuan University and Yunhai Biotechnology Reach Patent Transfer Agreement

On May 14, 2024, Chengdu Yunhai Tetrahedral Biotechnology Co., Ltd. and Sichuan University formally signed a patent transfer agreement, involving 26 key patents in the initial batch. This transfer marks a significant step in the commercialization of Sichuan University's research achievements in the field of tetrahedral nucleic acids and provides new technological momentum for Yunhai Biotechnology. This batch of patents represents the largest amount of intellectual property transfer recorded by the West China School of Stomatology at Sichuan University to date, and is also a milestone event for Yunhai Biotechnology, laying a solid foundation for future patent operations and industrialization of tetrahedral nucleic acids.

The signing of this patent transfer agreement is a crucial milestone in the strategic cooperation between Sichuan University and Yunhai Biotechnology. The two parties will continue to deepen their collaboration and explore the limitless possibilities in the field of tetrahedral nucleic acids. Yunhai Biotechnology will leverage these patented technologies to further develop innovative gene and drug delivery systems, providing more efficient and precise solutions for the global healthcare sector.